Cargando…

A reduced form of nicotinamide riboside defines a new path for NAD(+) biosynthesis and acts as an orally bioavailable NAD(+) precursor

OBJECTIVE: A decay in intracellular NAD(+) levels is one of the hallmarks of physiological decline in normal tissue functions. Accordingly, dietary supplementation with NAD(+) precursors can prevent, alleviate, or even reverse multiple metabolic complications and age-related disorders in diverse mod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giroud-Gerbetant, Judith, Joffraud, Magali, Giner, Maria Pilar, Cercillieux, Angelique, Bartova, Simona, Makarov, Mikhail V., Zapata-Pérez, Rubén, Sánchez-García, José L., Houtkooper, Riekelt H., Migaud, Marie E., Moco, Sofia, Canto, Carles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6807296/ https://www.ncbi.nlm.nih.gov/pubmed/31767171 http://dx.doi.org/10.1016/j.molmet.2019.09.013

Ejemplares similares

Nicotinamide Riboside and Dihydronicotinic Acid Riboside Synergistically Increase Intracellular NAD(+) by Generating Dihydronicotinamide Riboside
por: Ciarlo, Eleonora, et al.
Publicado: (2022)

Balancing NAD(+) deficits with nicotinamide riboside: therapeutic possibilities and limitations
por: Cercillieux, Angelique, et al.
Publicado: (2022)

Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage
por: Sambeat, Audrey, et al.
Publicado: (2019)

Nicotinamide riboside kinase 1 protects against diet and age-induced pancreatic β-cell failure
por: Cercillieux, Angelique, et al.
Publicado: (2022)

A Method to Monitor the NAD(+) Metabolome—From Mechanistic to Clinical Applications
por: Giner, Maria Pilar, et al.
Publicado: (2021)

Enzymatic and Chemical Syntheses of Vacor Analogs of Nicotinamide Riboside, NMN and NAD
por: Sverkeli, Lars Jansen, et al.
Publicado: (2021)

The emergence of the nicotinamide riboside kinases in the regulation of NAD(+) metabolism
por: Fletcher, Rachel S, et al.
Publicado: (2018)

NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
por: Ratajczak, Joanna, et al.
Publicado: (2016)

The Effect of Nicotinamide Riboside, an NAD + Precursor, on Glycolysis and NAD + Salvage Pathway in Alcohol-Stimulated Macrophages
por: Kang, Hyunju, et al.
Publicado: (2022)

Nicotinamide Riboside Kinase Structures Reveal New Pathways to NAD(+)
por: Tempel, Wolfram, et al.
Publicado: (2007)

The NAD(+) precursor nicotinamide riboside decreases exercise performance in rats
por: Kourtzidis, Ioannis A., et al.
Publicado: (2016)

NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health
por: Alegre, Gabriela Fabiana Soares, et al.
Publicado: (2023)

NAD(+) augmentation with nicotinamide riboside improves lymphoid potential of Atm(−/−) and old mice HSCs
por: Zong, Le, et al.
Publicado: (2021)

Exploring the therapeutic space around NAD(+)
por: Houtkooper, Riekelt H., et al.
Publicado: (2012)

Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
por: Trammell, Samuel A. J., et al.
Publicado: (2016)

Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells
por: Fletcher, Rachel S., et al.
Publicado: (2017)

NAD(+) homeostasis in human health and disease
por: Zapata‐Pérez, Rubén, et al.
Publicado: (2021)

Induction of the nicotinamide riboside kinase NAD(+) salvage pathway in a model of sarcoplasmic reticulum dysfunction
por: Doig, Craig L., et al.
Publicado: (2020)

NAD(+) to assess health in aging humans
por: Janssens, Georges E., et al.
Publicado: (2022)

Syntheses and chemical properties of β-nicotinamide riboside and its analogues and derivatives
por: Makarov, Mikhail V, et al.
Publicado: (2019)

Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD(+) in healthy middle-aged and older adults
por: Martens, Christopher R., et al.
Publicado: (2018)

Metabolic Disease, NAD Metabolism, Nicotinamide Riboside, and the Gut Microbiome: Connecting the Dots from the Gut to Physiology
por: Sauve, Anthony A.
Publicado: (2022)

Nicotinamide riboside and caffeine partially restore diminished NAD availability but not altered energy metabolism in Alzheimer's disease
por: Ryu, Woo‐In, et al.
Publicado: (2022)

Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD(+) Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures
por: Elhassan, Yasir S., et al.
Publicado: (2019)

Intravenous nicotinamide riboside elevates mouse skeletal muscle NAD(+) without impacting respiratory capacity or insulin sensitivity
por: Damgaard, Mads V., et al.
Publicado: (2022)

Rev1 deficiency induces a metabolic shift in MEFs that can be manipulated by the NAD(+) precursor nicotinamide riboside
por: Anugula, Sharath, et al.
Publicado: (2023)

Synthesis, Stability, and Bioavailability of Nicotinamide Riboside Trioleate Chloride
por: Zarei, Amin, et al.
Publicado: (2021)

Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin
por: Vreones, Michael, et al.
Publicado: (2022)

Dihydronicotinamide Riboside Is a Potent NAD(+) Precursor Promoting a Pro-Inflammatory Phenotype in Macrophages
por: Chini, Claudia C. S., et al.
Publicado: (2022)

Nicotinamide riboside kinases regulate skeletal muscle fiber-type specification and are rate-limiting for metabolic adaptations during regeneration
por: Sonntag, Tanja, et al.
Publicado: (2022)

ODP205 Hepatic steatosis induced by Nicotine plus Coca Cola is prevented by Nicotinamide riboside (NR) that increases mitochondrial NAD+
por: Friedman, Theodore C, et al.
Publicado: (2022)

NAD(+) Precursors: A Questionable Redundancy
por: Canto, Carles
Publicado: (2022)

NAD(+) metabolism as a target for metabolic health: have we found the silver bullet?
por: Connell, Niels J., et al.
Publicado: (2019)

An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers
por: Airhart, Sophia E., et al.
Publicado: (2017)

Equilibrative Nucleoside Transporters Mediate the Import of Nicotinamide Riboside and Nicotinic Acid Riboside into Human Cells
por: Kropotov, Andrey, et al.
Publicado: (2021)

Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
por: Dellinger, Ryan W., et al.
Publicado: (2017)

Defining NAD(P)(H) Catabolism
por: Dhuguru, Jyothi, et al.
Publicado: (2023)

Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
por: Dellinger, Ryan W., et al.
Publicado: (2018)

β-Nicotinamide Monucleotide Supplement with Astaxanthin and Blood Orange Enhanced NAD+ Bioavailability and Mitigated Age-Associated Physiological Decline in Zebrafish
por: Zhang, Doris, et al.
Publicado: (2022)

The significance of NAD + metabolites and nicotinamide N-methyltransferase in chronic kidney disease
por: Takahashi, Rina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ekvbgm60stqlep2auc4svp5hub